Gliciron

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Gliciron

What is Gliciron?

Gliciron is a pharmaceutical formulation primarily used in the management of chronic liver diseases and the improvement of abnormal liver function. It is a multi-component medication that combines several active substances to support hepatic health and address inflammatory processes within the liver.

Composition and Ingredients

The therapeutic effect of Gliciron is derived from a specific combination of ingredients, typically including:

  • Glycyrrhizin (Glycyrrhizic Acid): Extracted from licorice root, this compound is known for its anti-inflammatory and cytoprotective properties. It helps reduce liver enzyme levels and protects hepatocytes from damage.
  • Glycine: An amino acid that serves to mitigate the potential side effects of glycyrrhizin, such as pseudoaldosteronism, by helping to regulate metabolic responses.
  • DL-Methionine: An essential amino acid containing sulfur, which plays a role in detoxification processes and supports lipid metabolism in the liver.

Mechanism of Action

Gliciron works through several physiological pathways to promote liver recovery:

  1. Anti-inflammatory Activity: It inhibits the production of certain inflammatory mediators, thereby reducing the inflammation of liver tissue associated with chronic hepatitis.
  2. Hepatocyte Protection: The components work together to stabilize liver cell membranes, preventing the leakage of enzymes such as ALT and AST into the bloodstream.
  3. Metabolic Support: By providing essential amino acids, the formulation assists the liver in its natural regenerative and detoxification functions.

Clinical Applications

This medication is primarily indicated for patients dealing with persistent liver dysfunction. It is commonly utilized in the context of:

  • Chronic hepatitis
  • Compromised liver function resulting from various underlying pathologies
  • Allergic reactions or skin conditions where liver health plays a secondary role in systemic inflammation

Regulatory References

  1. WHO Model List of Essential Medicines
  2. Glibenclamide on WHO Essential Medicines List
  3. Glyburide (Glibenclamide) StatPearls Monograph

What side effects are possible with Gliciron?

Possible Side Effects and Safety Information: Gliciron (Glibenclamide)

The safety profile for Gliciron is defined by regulatory documents, which establish its officially listed adverse reactions and safety constraints. The most pharmacologically significant and Common adverse reaction is hypoglycaemia (low blood sugar), which can sometimes be severe, prolonged, or life-threatening.


Official Adverse Reactions and Systemic Groupings

Adverse effects are formally categorized into System-Organ Classes (SOCs). Reactions are frequently documented in the Metabolism and nutrition disorders, primarily hypoglycemia and weight gain. Gastrointestinal disorders may include nausea, heartburn, and upper abdominal fullness. Reactions affecting the Skin and subcutaneous tissue include rash, itching, and photosensitivity reactions (increased light sensitivity). Potential effects on the Hepatobiliary disorders include elevated liver enzymes and jaundice.


Serious Safety Considerations and Restrictions

Regulatory documents include warnings concerning severe, prolonged hypoglycemia and a Special Warning concerning increased cardiovascular mortality associated with this drug class. Specific population-specific safety statements advise against or limit use in several groups due to heightened risk. Use is restricted in older adults, those with severe renal impairment or hepatic impairment, and women who are pregnant or lactating.

Gliciron is formally contraindicated in conditions such as Type 1 Diabetes Mellitus, diabetic ketoacidosis, and concurrent use with the medicine bosentan. Hypoglycaemia is noted to be more likely when caloric intake is deficient or during unusual stress.

Overdose and Emergency Response

Gliciron overdose is officially documented as a medical emergency defined by profound and prolonged hypoglycemia due to excessive blood sugar reduction. The documented manifestations are categorized into two groups. Autonomic signs of overdose include anxiety, sweating, and rapid heartbeat (tachycardia). More severe neuroglycopenic signs reflect critical CNS involvement, presenting as confusion, stupor, slurred speech, convulsions, or coma.

The official regulatory profile emphasizes that severe hypoglycemia can lead to life-threatening outcomes, including permanent brain damage and death if uncorrected. When a Gliciron overdose is suspected, immediate medical attention must be sought, regardless of symptom severity. The presence of neurological signs like coma or seizures mandates prompt hospitalisation.

Treatment procedures officially described include the immediate administration of intravenous dextrose to raise blood sugar levels. Due to the drug's extended duration of action, hospital monitoring for a minimum of 12 to 24 hours is required to observe for the risk of delayed, recurrent hypoglycemia. Furthermore, official labeling specifies that ingestion of even a single tablet has the potential to cause life-threatening hypoglycemia in children. Patients who are elderly, debilitated, or have underlying renal or hepatic insufficiency are noted as being particularly susceptible to severe reactions.

Therapeutic Uses of Gliciron

Gliciron (Glibenclamide) is generally prescribed to address systemic imbalance and resulting symptoms characteristic of Type 2 Diabetes Mellitus. Its therapeutic application focuses on providing effective pharmacological support when non-drug interventions, such as diet and exercise, are generally insufficient to maintain blood sugar health. It is commonly used to help control blood sugar in adults with Type 2 Diabetes Mellitus.

The medication is commonly used to address conditions presenting with systemic imbalance, including chronic hyperglycemia and inadequate glucose regulation.


Managing Chronic High Blood Sugar and Symptom Relief

Gliciron is commonly used to help with persistent elevated sugar levels, which include symptoms related to systemic imbalance. It supports the achievement of stable, long-term glycemic control in adult patients.

“The medication assists with managing the chronic burden of high blood sugar, contributing to easing the overall symptom load.”


Supporting Long-Term Glycemic Control and Stability

It may be part of symptomatic management as monotherapy or combined with other antidiabetic agents, playing a role in the long-term achievement of glycemic targets. This assists with maintaining functional stability and supports patients in managing the overall symptom load associated with their condition.


Quick Fact: Relief for Systemic Imbalance Gliciron is commonly used to help with symptoms related to systemic imbalance, assisting patients with maintaining stability when symptoms become more noticeable.

Regulatory References

  1. Glyburide: MedlinePlus Drug Information

Eligibility and Restrictions for Use

The eligibility for using Gliciron (Glibenclamide) is strictly defined by official regulatory documentation, primarily limiting use to adults with Type 2 Diabetes Mellitus.

Contraindicated Populations

Use is contraindicated (must not be used) in several patient groups, including those with Type 1 Diabetes Mellitus and Diabetic Ketoacidosis (DKA). It is also prohibited for patients with a known hypersensitivity to Glibenclamide or related sulfonamide medications. Severe hepatic impairment and severe renal impairment are absolute exclusions from use.

Age and Life Stage Restrictions

Gliciron is generally not recommended for the pediatric population as safety and efficacy have not been established. Older adults require conservative dosing and careful monitoring due to an increased risk of hypoglycemia. The medication is contraindicated during pregnancy and for women who are breastfeeding; alternative therapy is required in both cases.

Conditional Use

Use is restricted during times of severe stress, such as major infection, trauma, or surgery, when temporary replacement with insulin is mandated by regulatory bodies.

What should I know about interactions with other medicines?

Gliciron, which belongs to the sulfonylurea class of antidiabetic medicines, has a broad and well-documented interaction profile with other medicinal products and substances. It is highly important to inform healthcare providers of all prescription, over-the-counter, and herbal supplements currently being taken to properly assess risk.

Potential Drug and Substance Interactions

Interactions with Gliciron are categorized by their clinical significance:

  • Major Interactions: These are highly clinically significant combinations that must generally be avoided, as the risk of the interaction outweighs the benefits. One example of a contraindicated combination is with bosentan, a medicine used for pulmonary hypertension.
  • Moderate Interactions: These are moderately significant, and the combination is usually avoided, requiring special caution, dosage adjustment, or increased monitoring if used together.
  • Minor Interactions: These interactions are minimally clinically significant, but monitoring may still be necessary to minimize any risk.

Interacting Product Categories

The effects of Gliciron can be either potentiated (leading to a higher risk of low blood sugar) or diminished (leading to a loss of blood sugar control) by other medicines. Examples of agents that may increase Gliciron's effect include certain nonsteroidal anti-inflammatory drugs (NSAIDs), salicylates (like aspirin), sulfonamides, and certain antibiotics (such as fluoroquinolones like ciprofloxacin). Conversely, medicines that may decrease Gliciron's effect include thiazide diuretics, corticosteroids, and thyroid products.


Other Important Interactions

Consuming alcohol while taking Gliciron can significantly increase the risk of severe low blood sugar. Additionally, the medicine colesevelam may reduce the absorption of Gliciron, requiring a four-hour separation between the administration of the two products. Individuals should also be aware that conditions like fever, trauma, or infection may temporarily affect blood sugar control, necessitating a review of the treatment plan.

Mechanism of Action

The mechanism of Gliciron (Glibenclamide) is defined by its targeted action within the insulin-producing pancreatic beta-cells, initiating a signaling cascade that triggers hormone release. This process operates through two primary mechanistic domains: the molecular blockade of an ion channel and the subsequent cellular signaling required for secretion.

Targeted Blockade of ATP-Sensitive Potassium Channels

The fundamental action involves Gliciron binding to the Sulfonylurea Receptor 1 ( SUR1) subunit of the ATP-sensitive potassium channel ( K ATP) complex on the beta-cell membrane. This interaction inhibits the channel's function, preventing the normal outflow of positive potassium ions ( K^+) and thereby directly causing a shift in the cell’s electrical charge.

Calcium-Dependent Insulin Secretion Cascade

The resulting electrical change (depolarization) forces the neighboring Voltage-Dependent Calcium Channels ( VDCC) to open, allowing a rapid influx of extracellular calcium ions ( Ca^2+). This surge in intracellular calcium acts as the final trigger for the exocytosis of pre-formed insulin granules. This molecular cascade produces the resulting physiological effect: an increase in circulating insulin levels. This increase is the physiological change enabling glucose uptake and utilization by muscle and adipose tissues.

Dosage and Administration Information

Gliciron (Glibenclamide) is administered via the oral route as a tablet and is intended for long-term use. Consistent use is structured by guidelines that dictate the appropriate initial amounts, the frequency of administration, and necessary adjustments for certain patient populations. The official administration guidelines standardize how the medicine is taken to ensure procedural adherence to the prescribed regimen.

Official Administration Guidelines

Feature Instruction
Route of administration The approved route is oral via tablet or suspension formulation.
Dosing schedule (Adults) Initial Dose (Standard Tablet): 2.5 mg to 5 mg once daily. The Maximum Daily Dose for standard tablets is 20 mg. Dose adjustments are applied in small increments at weekly intervals based on response.
Timing in relation to meals The medicine must be taken with breakfast or the first main meal of the day to ensure appropriate use.
Age-group administration rules Older Adults: Treatment should be initiated with conservative, low doses (e.g., 1.25 mg Standard).
Missed-dose rules If a dose is missed, take it when remembered, but do not take a double dose to compensate for the omission.
Special procedural conditions For higher daily doses (e.g., exceeding 10 mg Standard), the amount may be administered in divided doses. Switching between Standard and Micronized formulations requires dose re-titration

Connection to the Overall Use Protocol

The instructions define the mandatory oral route and the required timing with a meal, establishing the basic logistical framework for daily intake. The protocol sets a low-dose starting point and specifies the structured process of weekly titration, which controls the progression toward a necessary maintenance dose. This procedure ensures Gliciron is used consistently over the long term, adhering to standards for dose management.

Recent Clinical Evidence

Research Evidence and Overview of Studies for Gliciron

This overview describes the types of research and general patterns observed in studies of Gliciron (Glibenclamide), based on reports from regulatory bodies and peer-reviewed scientific literature. The information provided here focuses only on what researchers have studied and what the data so far suggest, without offering any clinical advice or guidance.


Evidence for use in Type 2 Diabetes Mellitus

Research exploring how Gliciron was studied for its association with outcomes related to blood sugar levels in adults with Type 2 Diabetes Mellitus consists of a substantial foundation of Randomized Controlled Trials (RCTs), as well as comprehensive systematic reviews and meta-analyses that combine findings from multiple studies. These studies primarily examine outcomes related to the body’s systemic or functional imbalance.

Researchers have monitored key physiological indicators, including measurements of Glycated Hemoglobin ( HbA1c), which provides insight into average blood sugar levels over a period of time, and outcomes monitoring Fasting Plasma Glucose levels. Findings from these trials describe patterns related to the measured shifts in HbA1c and FPG values when compared to settings where patients received no active treatment. Research also explored the relationship between different amounts of medication studied and the measured changes in blood sugar, with some findings indicating that measurements did not consistently report significantly greater changes beyond a certain amount of the medication studied.


Long-Term Studies and Durability of Response

Long-running diabetes research, including the UK Prospective Diabetes Study (UKPDS), evaluated Gliciron. These studies were structured as long-term observational follow-up efforts, tracking patients for decades, to explore the patterns of managing blood sugar early in the disease course. Research describes patterns where early, intensive approaches to blood sugar management was associated with outcomes reflecting changes in microvascular complication rates, even many years after the initial trial concluded. However, the studies also reported patterns where the management of blood sugar levels tended to become less noticeable over many years. Long-term effects on physiological strain or stress are not fully established, and this remains an area that research continues to examine.


Evidence in Specific Patient Populations

Most research for Gliciron was studied for use in adults with Type 2 Diabetes. However, the medicine was also studied for use in a specific, rare, genetically-defined patient population outside of Type 2 diabetes. This research, based on observational studies and case series, focused on infants and children diagnosed with a rare form of Neonatal Diabetes Mellitus caused by certain gene changes. Studies monitored HbA1c values and blood glucose control in these specific pediatric populations. The findings describe group patterns related to the stability of blood sugar management after affected patients were transitioned from injectable insulin to the oral medication.

Key Studies & References

  1. Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials
  2. A systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other secretagogues and with insulin

Frequently Asked Questions (FAQ)

Common questions about Gliciron (FAQ)

Q: Why did my doctor prescribe Gliciron?

Gliciron is officially indicated for the metabolic management of high blood sugar, also known as hyperglycemia, in adults with Type 2 Diabetes Mellitus. According to regulatory documents, it is indicated for use along with diet and physical activity for the purpose of managing blood sugar levels.


Q: Does Gliciron treat [specific condition, e.g., high blood sugar]?

Official product information states that Gliciron is indicated to help lower blood glucose (blood sugar) in patients with Type 2 Diabetes Mellitus. This medication's action is defined by its role in assisting the body's management of blood sugar levels, contributing to glycemic control.


Q: Does Gliciron have an interaction with alcohol?

Yes, official warnings indicate that consuming alcohol while taking Gliciron can significantly increase the risk of a severe hypoglycemic reaction, meaning dangerously low blood sugar. Regulatory documents state that avoiding or limiting alcohol consumption is typically recommended due to this risk.


Q: What foods or supplements should I avoid while on Gliciron?

In addition to alcohol, official documents warn that some medicines or substances may impact Gliciron's effectiveness. For instance, the medicine colesevelam may reduce the absorption of Gliciron. Some official sources also caution that the herbal supplement St. John's Wort may decrease the effect of the medication.


Q: Does Gliciron need to be taken with food?

Official administration guidelines state that Gliciron is administered with breakfast or the first main meal of the day. This timing is a condition of use described in the product information.


Q: How long do the effects of Gliciron last?

Glibenclamide, the active ingredient in Gliciron, is described in regulatory documents as having a prolonged hypoglycemic effect. Its activity is consistent with a regimen that is typically administered once daily.


Q: Can Gliciron affect how birth control pills work?

Yes, official drug interaction warnings indicate that hormone therapy or oral birth control pills may potentially decrease the effect of Gliciron. If the effect of Gliciron is reduced, this could lead to elevated blood sugar levels, and therefore, medical supervision or assessment may be necessary.


Q: Are there any known interactions between Gliciron and herbal supplements?

Regulatory information specifically mentions the herbal preparation St. John's Wort (also known as Hypericum perforatum). This supplement may decrease the effectiveness of Gliciron, potentially leading to a loss of blood sugar control.


Q: Does Gliciron interact with grapefruit or grapefruit juice?

Based on research cited by the NIH, grapefruit juice has not been shown to change the way the body handles the active ingredient in Gliciron. Patients should still communicate any significant dietary changes to their healthcare provider.


Q: What kind of monitoring is usually required when taking Gliciron?

The medical management of Gliciron therapy involves regular assessment of laboratory values. This process includes monitoring blood glucose levels and glycosylated hemoglobin ( HbA1c) to help determine the individual's response to the treatment.


Q: Is Gliciron available as a generic medicine?

Yes, the active ingredient in Gliciron, Glibenclamide (also known as Glyburide), is widely available as a generic medication in many countries, as confirmed by national health information sources.


Q: What does the patient leaflet say about driving while using Gliciron?

Regulatory information advises that the ability to drive or operate machinery may be affected if the patient experiences a hypoglycemic event (low blood sugar). Because low blood sugar is a known adverse reaction, awareness of potential symptoms is noted in regulatory information.


Q: Can Gliciron make me sensitive to the sun?

Yes, official adverse reaction listings include photosensitivity reactions, which means an increased sensitivity to light, as a possible effect on the skin. Regulatory documents note that patients may need to take precautions regarding sun exposure.


Q: Why is Gliciron described as a 'first-line' or 'second-line' treatment?

While the specific terminology may vary, the drug is generally noted in its class for use in patients who cannot be adequately managed with foundational therapies alone. In some contexts, it is noted for use in patients who have not achieved their blood sugar goals with standard initial therapy.


Q: Can Gliciron cause changes in mood?

While mood change is not listed as a primary side effect, the official symptoms of a serious adverse reaction, hypoglycemia (low blood sugar), can include changes in mental state. These symptoms are noted to include confusion, irritability, or even depression.


Q: Does Gliciron cause weight gain or weight loss?

Regulatory documents list weight gain as a frequently documented adverse reaction for Gliciron. This is noted as one of the possible effects on the body’s metabolism and nutrition.


Q: Why do people stop taking Gliciron?

Discontinuation is noted in studies due to various reasons, including the drug losing its full effectiveness over time, known as secondary failure. Other reasons involve the risk of severe hypoglycemia or the cardiovascular risk associated with the sulfonylurea drug class, as noted in official warnings, which may lead to a treatment review.


Q: Is Gliciron intended to be a permanent medication?

The medication is structured for long-term use and has been the subject of long-running studies for managing Type 2 Diabetes Mellitus. However, its effectiveness may diminish over many years, and the treatment plan is subject to regular review.


Q: How do I know if Gliciron is working for me?

The effectiveness of the medicine is assessed through regular clinical measurements. This primarily involves the monitoring of blood glucose levels and glycosylated hemoglobin ( HbA1c) test results to gauge the therapeutic response.

How should Gliciron be stored and disposed of?

How to Store and Dispose of Gliciron (Tolbutamide Tablets)

Tolbutamide tablets must be stored at controlled room temperature, maintaining a range of 20 C to 25 C (68 F to 77 F). The product must be protected from light and excess moisture to ensure stability. Keep the medication in the container it came in, ensure it is tightly closed, and store it out of the sight and reach of children.


Disposal Requirements

To dispose of unused or expired Gliciron, utilize a drug take-back program. If one is unavailable, follow U.S. FDA guidelines for household disposal: mix the tablets with an undesirable substance, place the mixture in a sealed container, and discard it in the trash. Do not flush this medicine down a sink or toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Gliciron found in:

A-Z Index: